NAVARRO LÓPEZ, Vicente Manuel,RAMÍREZ BOSCÁ, Ana Adela,PÉREZ ORQUÍN, José Manuel,RAMÓN VIDAL, Daniel,GENOVÉS MARTÍNEZ, Salvador,CHENOLL CUADROS, María Empar,CODOÑER CORTÉS, Francisco Manuel
申请号:
MA44893
公开号:
MA44893A1
申请日:
2017.07.18
申请国别(地区):
MA
年份:
2019
代理人:
摘要:
The present invention relates to the use of probiotic compositions containing animal bifidobacteria. Lactis (B. Lactis), Bifidobacterium Longum and Lactobacillus Casei strains, especially B. Lactis CECT 8145, B. Longum CECT 7347 and/or L. Casei CECT 9104, are used to treat and/or prevent atomic dermatitis.La présente invention concerne l'utilisation d'une composition probiotique comprenant bifidobacterium animalis subsp. Lactis (b. Lactis), bifidobacterium longum et lactobacillus casei, en particulier les souches b. Lactis cect 8145, b. Longum cect 7347 et/ou l. Casei cect 9104, dans le traitement et/ou la prévention de la dermatite atopique.